Practice Test Geeks(CCA) CATO Certified Associate Practice Test
← All CCA Flashcard Decks

CATO Associate Investigational Product Management Flashcards

6 cards from real CCA practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 6 CATO Associate Investigational Product Management flashcards as text

  1. What is the purpose of a drug reconciliation at the end of a clinical trial?

    Answer: To verify that all dispensed, returned, and destroyed IP quantities balance with what was received

    Drug reconciliation confirms that all IP received is accounted for through dispensing records, subject returns, and destruction documentation.

  2. What is a 'medication error' in the context of investigational product management?

    Answer: Any unintended exposure of a subject to the wrong IP dose, route, or product

    A medication error is any unintended deviation in the administration of IP—wrong dose, wrong route, wrong subject, or wrong product.

  3. What does 'blinded randomization' require of the IP packaging and labeling?

    Answer: Active and placebo must be indistinguishable in appearance and labeled with only a randomization code

    Blinded trial packaging requires active and placebo to look identical, with labels bearing only a code so that neither site staff nor subjects can identify the treatment.

  4. Under GCP, how long must IP accountability records typically be retained after the trial ends?

    Answer: Per sponsor/regulatory requirements, typically at least 2–15 years depending on jurisdiction

    IP accountability records must be retained per applicable regulatory requirements and sponsor instructions, commonly ranging from 2 to 15+ years.

  5. When a clinical site receives a shipment of investigational product, what should be done first?

    Answer: Inspect the shipment, verify contents against the packing list, and check storage conditions were maintained during transit

    Upon IP receipt, the site must inspect the shipment for damage, verify quantities against the packing list, and confirm transit temperature logs before accepting the product.

  6. What is an 'emergency unblinding' procedure in the context of IP management?

    Answer: A process allowing rapid disclosure of a subject's treatment assignment when medically necessary

    Emergency unblinding allows rapid determination of a subject's treatment assignment when knowledge is essential for the subject's medical management.